Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol

被引:61
作者
Lin, GR [1 ]
Oram, JF [1 ]
机构
[1] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
关键词
high-density lipoproteins (HDL); cardiovascular disease; lipid-free HDL;
D O I
10.1016/S0021-9150(99)00503-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High-density lipoproteins (HDL) are believed to protect against cardiovascular disease by removing excess cholesterol from cells. Lipid-free HDL apolipoproteins remove cellular cholesterol and phospholipids by an active, Golgi-dependent process that is still poorly understood. Here we characterized the morphology of apolipoprotein binding sites on cultured cells by immunogold electron microscopy. After 6 h incubations with lipid-free apoA-I or apoE, immunogold-labeled apolipoproteins were distributed sparsely along the planar surface of human fibroblasts and THP-1 macrophages. Overloading these cells with cholesterol led to a several-fold increase in the concentration of immunogold-labeled apoA-I and apoE on the cell surface, acid over 80% of these gold particles were associated with novel electron-opaque structures protruding from the plasma membrane. Protrusions binding apoE were larger (100-200 nm) than those binding apoA-I (10-60 nm), and similar apoA-I-binding structures appeared when cells were incubated with either purified apoA-I or HDL particles. These structures were formed and enlarged by a time-dependent process inhibited by the Golgi disrupter brefledin A, the energy poison NaF, and low temperature. Moreover, formation of these structures was nearly absent in fibroblasts from a subject with Tangier disease, cells that lack a functioning ape lipoprotein-mediated lipid removal pathway. Thus, formation of novel apolipoprotein binding structures protruding from the cell surface is an intermediate step in the cellular pathway by which apolipoproteins remove excess cholesterol. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:359 / 370
页数:12
相关论文
共 59 条
[1]  
Assmann G, 1995, METABOLIC MOL BASES, P2053
[2]   Role of free apolipoprotein A-I in cholesterol efflux - Formation of pre-alpha-migrating high-density lipoprotein particles [J].
Asztalos, B ;
Zhang, WW ;
Roheim, PS ;
Wong, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) :1630-1636
[3]   PRESENCE AND FORMATION OF FREE APOLIPOPROTEIN A-I-LIKE PARTICLES IN HUMAN PLASMA [J].
ASZTALOS, BF ;
ROHEIM, PS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1419-1423
[4]  
AUWERX JH, 1988, ARTERIOSCLEROSIS, V8, pA567
[5]   Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae [J].
Babitt, J ;
Trigatti, B ;
Rigotti, A ;
Smart, EJ ;
Anderson, RGW ;
Xu, SZ ;
Krieger, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) :13242-13249
[6]  
BIELICKI JK, 1992, J LIPID RES, V33, P1699
[7]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[8]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[9]   CHOLESTERYL ESTER TRANSFER PROTEIN AND HEPATIC LIPASE ACTIVITY PROMOTE SHEDDING OF APO A-I FROM HDL AND SUBSEQUENT FORMATION OF DISCOIDAL HDL [J].
CLAY, MA ;
NEWNHAM, HH ;
FORTE, TM ;
BARTER, PI .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1124 (01) :52-58
[10]  
FIELDING CJ, 1995, J LIPID RES, V36, P211